Professor of Pathology, Microbiology & Immunology and Professor of Pharmacology
Vanderbilt Univ Medical Ctr
Dr. Elizabeth Phillips is a physician scientist clinically trained in Infectious diseases, immunology and clinical pharmacology who has established new clinical and research programs in drug hypersensitivity, pharmacogenomics and personalized immunology across different healthcare systems. She has published over 400 peer reviewed articles and book chapters related to hypersensitivity reactions to drugs and vaccines. She is recognized for elucidating mechanisms and genetic determinants of drug hypersensitivity which have transformed research, clinical practice and training in the United States and Internationally. Her discovery through translation pipeline continues to pioneer strategies to prevent, diagnose and mitigate harm from true drug hypersensitivity and she is applying novel technologies to understand the single cell pathology of drug hypersensitivity at the site of tissue damage leading to identification of new therapeutic targets. She has also led development of clinical practice and guidance dedicated to the care of drug hypersensitivity patients and her clinics have acted as a model for others within the US and internationally. Her efforts have transformed care across multiple disciplines and she is a true community leader and advocate for those with severe cutaneous adverse drug reactions, working alongside patients and foundations to advance education, awareness and science of drug hypersensitivity.
Disclosure information not submitted.
Symposium 13: Advancements in Understanding Drug-induced Hypersensitivity Reactions
Tuesday, September 10, 2024
10:00 AM – 11:30 AM ET
3 - Drug-induced Severe Cutaneous Adverse Reactions
Tuesday, September 10, 2024
10:00 AM – 11:30 AM ET